Corcept Therapeutics Inc

Most Recent

  • uploads///puzzle _
    Company & Industry Overviews

    NovoCure Stock Rose after Positive Results from Clinical Trial

    On September 6, NovoCure (NVCR) stock rose 5.3% to reach $45.40.

    By Daniel Collins
  • uploads///cushing syndrome
    Company & Industry Overviews

    Teva Sued by Corcept Therapeutics over Patent Infringement Claim

    On March 15, 2018, Corcept Therapeutics announced that it had filed a lawsuit against Teva Pharmaceutical for the infringement of its Korlym patents.

    By Sarah Collins
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.